ABclonal Technology

ABclonal Technology

Biotechnology

Woburn, Massachusetts 10,886 followers

Meeting your research needs, one target at a time. Click below or email us at service@abclonal.com for more information

About us

Based in Massachusetts, ABclonal is a dynamic and growing provider of biology research reagents and services. With scientists from world-class universities, we thrive to improve the quality of life science research by providing high-quality antibodies, proteins, ELISA kits, NGS Prep Kits and molecular enzymes. ABclonal has a comprehensive prokaryotic and eukaryotic protein expression system, advanced mouse monoclonal antibody production system and a fourth-generation rabbit monoclonal antibody technology. Our advanced technology allows the development of in vitro diagnostic products and customized IVD materials used in the early research and development of raw materials development services. Our clients span across the globe, including internationally renowned corporations, such as Novartis, Genetek, BGI Genomics, Novogene, 3DMed, and Maxim. #Biotechnology #LifeScience #Antibody #ResearchTools

Industry
Biotechnology
Company size
501-1,000 employees
Headquarters
Woburn, Massachusetts
Type
Privately Held
Founded
2011
Specialties
Antibodies, Peptide synthesis, Custom antibodies service, Protein, and Protein Expression

Locations

  • Primary

    500 W Cummings Park

    Ste. 6500

    Woburn, Massachusetts 01801, US

    Get directions

Employees at ABclonal Technology

Updates

  • 🎄 Merry Christmas from ABclonal! 🎄 As we reflect on a year full of innovation and progress, we want to take a moment to thank our incredible team, partners, and customers for their continued support. This holiday season, we celebrate the spirit of discovery and collaboration that drives us all forward. Wishing you a joyful Christmas and a prosperous New Year filled with health, happiness, and new breakthroughs in science!

    • No alternative text description for this image
  • Gasdermin proteins are key players in inflammatory cell death, driving conditions like cancer, autoimmune diseases, and chronic inflammation. In our latest blog, we explore how these proteins form pores in cell membranes, releasing inflammatory cytokines and shaping immune responses. Want to learn more about their potential for future therapies? Read the full article now! 🌐 https://hubs.li/Q02-7RpF0 #Pyroptosis #CellDeath #Gasdermin #CancerResearch #Biotech #Inflammation

    • No alternative text description for this image
  • We’re proud to see ABclonal’s A17909 AKT1 Rabbit mAb cited in Advanced Science for the publication, "Short-Term Statin Therapy Induces Hepatic Insulin Resistance Through the HNF4α/PAQR9/PPM1α Axis Regulated AKT Phosphorylation." This paper delves into how statin therapy impacts hepatic insulin resistance by disrupting key signaling pathways. With findings that highlight the HNF4α-PAQR9-PPM1α axis, the study offers fresh perspectives on statin-induced metabolic effects and potential interventions. Discover the full study here: https://hubs.li/Q02_5lSh0 Learn more about A17909 AKT1 Rabbit mAb: https://hubs.li/Q02_5lQr0

    • No alternative text description for this image
  • Some of our ABclonal team members will be joining Yurogen at this Global Antibody Flagship Event to share insights. 😊 Come visit us at Booth #508!

    View organization page for Yurogen Biosystems LLC, graphic

    1,416 followers

    Yurogen is thrilled to be part of the Antibody Engineering & Therapeutics (AET) conference in San Diego, happening December 15-18, 2024! 🧬✨ 🗓️ Time: December 15-18, 2024 📍 Location: Marriott Marquis San Diego Swing by Booth #508 and meet our team! We're showcasing our expertise in antibody discovery, protein expression and sharing the latest on our SMab™ technology, redefining high-affinity antibody development. Let's connect, exchange ideas, and push the boundaries of what's possible. We can't wait to meet you at AET! 👉 For event details, check out: [https://hubs.li/Q02-LHYT0]

    • No alternative text description for this image
  • 🔬 Big News for Researchers! ❄️ We're thrilled to announce the launch of our new 100 µL Antibody Subscription Plan, coming this December—perfect for labs running multiple assays per target. ✔️ More Flexibility: A larger unit size to suit your experimental needs. ✔️ Cost Efficiency: Simplified budgeting with predictable pricing. ✔️ Time Savings: Streamlined ordering to focus more on breakthroughs. Ready to elevate your lab's workflow? Explore the possibilities with ABclonal's 100 µL antibody subscription plan today! 👉 https://hubs.li/Q02-JDTb0

    • No alternative text description for this image
  • Pyroptosis is an inflammatory form of cell death that plays a crucial role in immune defense. Triggered by inflammasomes and caspases, it leads to cell rupture and the release of pro-inflammatory cytokines. In our newest blog, we explore the mechanisms behind pyroptosis, focusing on the critical role of gasdermin proteins like GSDMD. Want to learn more about how this process shapes immune responses? Read the full article here! 🌐 https://hubs.li/Q02-pfMl0

    • No alternative text description for this image
  • 🎄 Join ABclonal at the Holiday Biotech Community Event! 🎄 We’re excited to be part of the Holiday Biotech Community Event at Tech Square, Cambridge, on Dec 4th! It’s the perfect opportunity to connect with fellow biotech professionals, celebrate the season, and discuss the latest innovations in life sciences. ✨ Event Highlights: -Network with industry experts and leaders -Discover ABclonal's cutting-edge products -Celebrate with delicious food and festive cheer! Don’t miss this chance to connect, collaborate, and get into the holiday spirit with ABclonal! See you there! 🎉

    • No alternative text description for this image

Similar pages

Browse jobs

Funding